Weight Loss (GLP-1)

A medically supervised weight management programme built around GLP-1 receptor agonists such as semaglutide and tirzepatide. These medications mimic the gut hormone GLP-1 to slow gastric emptying, reduce appetite and quieten food noise. They are prescribed after screening and combined with nutrition, protein and resistance-training guidance so weight lost is fat rather than muscle.

• Clinically significant, sustained appetite reduction
• Improved blood glucose control and metabolic markers
• Weekly injection you administer at home
• Full medical supervision with dose titration
• Nutrition and muscle-preservation coaching included

1. 01

   Medical consultation, weight history, baseline labs and BMI assessment

2. 02

   Prescription and a supervised titration schedule starting at the lowest dose

3. 03

   Training on self-injection technique and storage

4. 04

   Monthly reviews for tolerance, dose adjustment and progress

5. 05

   Guidance on protein intake and resistance training throughout

Adults with a BMI of 30 or above, or 27 or above with a weight-related condition. Not suitable in pregnancy or when planning pregnancy, with a personal or family history of medullary thyroid carcinoma or MEN2, a history of pancreatitis, or active eating disorder.

• Rotate injection sites weekly
• Prioritise protein at every meal and stay hydrated
• Resistance training two to three times weekly to protect muscle
• Report severe or persistent abdominal pain immediately

• How much weight will I lose?

  Trial data shows roughly 15–20% of body weight over 12 months with full adherence, though individual results vary.

• What are the side effects?
• What happens when I stop?
• Will my face look gaunt?